Guy Alexander Zimmerman
Physician in Salt Lake City, UT
License number
Utah 160636-1205
Issued Date
Apr 20, 1977
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Personal information
See more information about Guy Alexander Zimmerman at radaris.comName
Address
Phone
1943 Yale Ave, Salt Lake Cty, UT 84108
1943 E Yale Ave, Salt Lake City, UT 84108
6479 Clematis Way, West Jordan, UT 84081
1943 Yale Ave, Salt Lake Cty, UT 84108
1943 Yale Ave, Salt Lake City, UT 84108
Professional information
Quality Manager At Chg Healthcare
Position:
Quality Management Supervisor at CHG Healthcare Services
Location:
Greater Salt Lake City Area
Industry:
Hospital & Health Care
Work:
CHG Healthcare Services
since Nov 2010
-
Quality Management Supervisor
Jordan Valley Medical Center
Oct 2009 - May 2010
-
NURSE CASE MANAGER
COZY Home Healthcare & Hospice
Dec 2007 - Oct 2009
-
NURSE CASE MANAGER
Highland Ridge Hospital, Pioneer Behavioral Health, Inc.
Aug 2006 - Dec 2007
-
DIrector of Nursing
Salt Lake Regional Medical Center
May 2005 - May 2006
-
CASE MANAGER
Zurich North America Insurance
Apr 2002 - Apr 2005
-
NURSE CONSULTANT / KEY ACCOUNT MANAGEMENT
Pioneer Valley Hospital ER (IASIS)
Jul 2000 - Dec 2002
-
CHARGE RN
Rocky Mountain Medical Center (IASIS)
Feb 2000 - Jul 2000
-
DIRECTOR OF EMERGENCY SERVICES
Pioneer Valley Hospital ER (IASIS)
Apr 1998 - Feb 2000
-
CHARGE RN
Columbia Home Care
Jan 1997 - Apr 1998
-
CLINICAL COORDINATOR
HOME INFUSION SERVICES
Aug 1996 - Jan 1997
-
DIRECTOR
FHP HOME HEALTH
May 1996 - Aug 1996
-
CASE MANAGER
FHP HOSPITAL
Jul 1993 - Jun 1996
-
CHARGE NURSE INTENSIVE CARE & EMERGENCY ROOM
Loma Linda University Medical Center
Jun 1989 - Apr 1993
-
RN, CHARGE NURSE, CARDIAC ICU
Education:
Marylhurst University 2015
Master of Business Administration (MBA), Business Administration and Management, General University of Phoenix 2001 - 2003
BS, Business/Marketing Los Angeles Harbor College 1986 - 1989
ADN, Registered Nurse
Master of Business Administration (MBA), Business Administration and Management, General University of Phoenix 2001 - 2003
BS, Business/Marketing Los Angeles Harbor College 1986 - 1989
ADN, Registered Nurse
Quality Manager At Chg
Position:
Quality Management Supervisor at CHG Healthcare Services
Location:
Greater Salt Lake City Area
Industry:
Hospital & Health Care
Work:
CHG Healthcare Services
since Nov 2010
-
Quality Management Supervisor
Jordan Valley Medical Center
Oct 2009 - May 2010
-
NURSE CASE MANAGER
COZY Home Healthcare & Hospice
Dec 2007 - Oct 2009
-
NURSE CASE MANAGER
Highland Ridge Hospital, Pioneer Behavioral Health, Inc.
Aug 2006 - Dec 2007
-
DIrector of Nursing
Salt Lake Regional Medical Center
May 2005 - May 2006
-
CASE MANAGER
Zurich North America Insurance
Apr 2002 - Apr 2005
-
NURSE CONSULTANT / KEY ACCOUNT MANAGEMENT
Pioneer Valley Hospital ER (IASIS)
Jul 2000 - Dec 2002
-
CHARGE RN
Rocky Mountain Medical Center (IASIS)
Feb 2000 - Jul 2000
-
DIRECTOR OF EMERGENCY SERVICES
Pioneer Valley Hospital ER (IASIS)
Apr 1998 - Feb 2000
-
CHARGE RN
Columbia Home Care
Jan 1997 - Apr 1998
-
CLINICAL COORDINATOR
HOME INFUSION SERVICES
Aug 1996 - Jan 1997
-
DIRECTOR
FHP HOME HEALTH
May 1996 - Aug 1996
-
CASE MANAGER
FHP HOSPITAL
Jul 1993 - Jun 1996
-
CHARGE NURSE INTENSIVE CARE & EMERGENCY ROOM
Loma Linda University Medical Center
Jun 1989 - Apr 1993
-
RN, CHARGE NURSE, CARDIAC ICU
Education:
University of Phoenix 2001 - 2003
BS, Business/Marketing Los Angeles Harbor College 1986 - 1989
ADN, Registered Nurse
BS, Business/Marketing Los Angeles Harbor College 1986 - 1989
ADN, Registered Nurse
Skills:
Team Building, EMR, Healthcare Information Technology, EHR, Software Documentation, Management
Guy Zimmerman, Salt Lake City UT
Work:
Uumc Pulmonary Dept
50 N Medical Dr, Salt Lake City, UT 84132
50 N Medical Dr, Salt Lake City, UT 84132
Professor Of Medicine At University Of Utah
Position:
Professor of Medicine at University of Utah
Location:
Greater Salt Lake City Area
Industry:
Market Research
Work:
University of Utah
-
Professor of Medicine
Professor Of Medicine At University Of Utah
Position:
Professor of Medicine at University of Utah
Location:
Greater Salt Lake City Area
Industry:
Market Research
Work:
University of Utah
-
Professor of Medicine
Use Of Pre-Mrna Splicing In Platelet Cells For The Diagnosis Of Disease
US Patent:
2010029, Nov 25, 2010
Filed:
Jun 20, 2008
Appl. No.:
12/452333
Inventors:
Andrew S. Weyrich - Salt Lake City UT, US
Hansjorg Schwertz - Salt Lake City UT, US
Guy Zimmerman - Salt Lake City UT, US
Neal Tolley - Salt Lake City UT, US
Hansjorg Schwertz - Salt Lake City UT, US
Guy Zimmerman - Salt Lake City UT, US
Neal Tolley - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention relates to materials and procedures for identifying or using tissue factor (TF) pre-mRNA splicing, CIk 1 activity or TF-dependent coagulation in platelet cells for the diagnosis, prognosis, or prediction of a disease or disorder associated with disordered coagulation. Since activated platelets splice pre-mRNAs to generate inflammatory and thrombotic mediators that contribute to diseases such as sepsis and septic shock, (TF) pre-mRNA splicing in platelets is an indicator of inflammatory and thrombotic disease states. TF pre-mRNA splicing in platelets is correlated with sepsis, increased age (≧65), APACHE II score, and bacteremia. Thus, TF mRNA expression patterns in platelets may be used for the diagnosis, prognosis, or prediction of a disease or disorder associated with disordered coagulation, for example, patients that are at a higher risk for severe sepsis, organ failure, and death.
Signal-Dependent Splicing Of Tissue Factor Pre-Mrna In Platelet Cells
US Patent:
2009004, Feb 12, 2009
Filed:
Jun 20, 2008
Appl. No.:
12/143645
Inventors:
Andrew S. Weyrich - Salt Lake City UT, US
Hansjorg Schwertz - Salt Lake City UT, US
Guy Zimmerman - Salt Lake City UT, US
Neal Tolley - Salt Lake City UT, US
Hansjorg Schwertz - Salt Lake City UT, US
Guy Zimmerman - Salt Lake City UT, US
Neal Tolley - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
A61K 31/54, C12Q 1/68, C40B 30/06, G01N 33/00, A61P 7/00, C40B 30/08, C12Q 1/02
US Classification:
5142242, 435 6, 506 10, 436 86, 506 11, 435 29
Abstract:
The invention relates to therapeutic target recognition, development, and validation of a compound capable of directly or indirectly modulating TF pre-mRNA splicing in a platelet cell and the use of a platelet TF pre-mRNA splicing modulator for the treatment of a subject suffering from, or thought to be suffering from, disordered coagulation.
Terminally-Differentiated Anucleate Platelet Progeny Generation
US Patent:
2011029, Dec 1, 2011
Filed:
Oct 7, 2009
Appl. No.:
13/122886
Inventors:
Hansjorg Schwertz - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
International Classification:
A61K 38/02, A61K 31/7072, A61K 31/551, A61K 31/496, A61K 31/536, A61P 7/00, A61K 31/203, A61K 31/708, A61K 31/7068, A61K 31/513, A61K 31/52, C12N 5/078, A61K 31/505
US Classification:
514 135, 435325, 435391, 514 50, 514220, 51425309, 5142305, 514272, 514559, 514 45, 514 49, 514274, 5142634
Abstract:
Platelets are induced to proliferate, form extensions and produce daughter cells by various methods, including culturing platelets under thrombocytopenic conditions. Expansion of platelet cell numbers increases the storage life of platelets. Modulation of RT activity can be used to produce new daughter platelets. Therefore, the invention provides a new therapeutic use for RT inhibitors that can now be used for treatment of thrombocytopenia and related disorders. Likewise, application of soluble protein factor that may be secreted and/or released by platelets cultured under thrombocytopenic conditions may also be used as a therapeutic agent to increase platelet numbers.